Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

More articles from Erratum

  • You have access
    CORRECTION TO “CYTOCHROME P450 EXPRESSION AND REGULATION IN CYP3A4/CYP2D6 DOUBLE TRANSGENIC HUMANIZED MICE”
    Drug Metabolism and Disposition July 2009, 37 (7) 1563; DOI: https://doi.org/10.1124/dmd.37.7.1563
  • You have access
    CORRECTION TO “A COMBINED MODEL FOR PREDICTING CYP3A4 CLINICAL NET DRUG-DRUG INTERACTION BASED ON CYP3A4 INHIBITION, INACTIVATION, AND INDUCTION DETERMINED IN VITRO”
    Drug Metabolism and Disposition September 2008, 36 (9) 1975; DOI: https://doi.org/10.1124/dmd.36.9.1975
  • You have access
    CORRECTION TO “IDENTIFICATION AND CHARACTERIZATION OF POTENT CYP2B6 INHIBITORS IN WOOHWANGCHEONGSIMWON SUSPENSION, AN HERBAL PREPARATION USED IN THE TREATMENT AND PREVENTION OF APOPLEXY IN KOREA AND CHINA”
    Drug Metabolism and Disposition August 2008, 36 (8) 1736; DOI: https://doi.org/10.1124/dmd.36.8.1736
  • You have access
    CORRECTION TO “THE DEVELOPMENT OF DRUG METABOLISM RESEARCH AS EXPRESSED IN THE PUBLICATIONS OF ASPET: PART 1, 1909–1958”
    Drug Metabolism and Disposition March 2008, 36 (3) 622; DOI: https://doi.org/10.1124/dmd.36.3.622
  • You have access
    CORRECTION TO “USE OF ISOLATED HEPATOCYTE PREPARATIONS FOR CYTOCHROME P450 INHIBITION STUDIES: COMPARISON WITH MICROSOMES FOR KI DETERMINATION”
    Drug Metabolism and Disposition January 2008, 36 (1) 203; DOI: https://doi.org/10.1124/dmd.36.1.203
  • You have access
    CORRECTION TO “IN VITRO METABOLIC STUDY OF TEMSIROLIMUS: PREPARATION, ISOLATION, AND IDENTIFICATION OF THE METABOLITES”
    Drug Metabolism and Disposition November 2007, 35 (11) 2138; DOI: https://doi.org/10.1124/dmd.35.11.2138
  • You have access
    CORRECTION TO “THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS OF HUMAN CYP51 INHIBITORS”
    Drug Metabolism and Disposition July 2007, 35 (7) 1246; DOI: https://doi.org/10.1124/dmd.35.7.1246
  • You have access
    Correction to “Stereoselective Metabolism of Endosulfan by Human Liver Microsomes and Human Cytochrome P540 Isoforms”
    Drug Metabolism and Disposition May 2007, 35 (5) 829-830; DOI: https://doi.org/10.1124/dmd.35.5.829
  • You have access
    CORRECTION TO “NEUROTOXIC PYRIDINIUM METABOLITES OF HALOPERIDOL ARE SUBSTRATES OF HUMAN ORGANIC CATION TRANSPORTERS”
    Drug Metabolism and Disposition December 2006, 34 (12) 2117; DOI: https://doi.org/10.1124/dmd.34.12.2117
  • You have access
    Correction To “Glutathione S-Transferase Omega 1 and Omega 2 Pharmacogenomics”
    Drug Metabolism and Disposition September 2006, 34 (9) 1666; DOI: https://doi.org/10.1124/dmd.34.9.1666

Pages

  • Previous
  • Next
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics